UPMC ranks display systems for pathology
When the University of Pittsburgh Medical Center's (UPMC) pathology department conducted a pathology visualization study, Barco's Coronis Fusion 6MP DL medical display outscored other display modalities in a comparison that included consumer displays and medical displays, when viewing whole-slide images (WSI).
At UPMC, researchers conducted a study in which 60 WSI cases were viewed over a three-month period using five different systems: a standard 14-inch laptop computer display, a standard 24-inch desktop display, an optical microscope and two different medical grade displays, one of which was a Barco Coronis Fusion 6MP DL system. The purpose of the study was to compare the user experience among different display options.
The Coronis Fusion 6MP DL medical display ranked comparably to the optical microscope for image quality and diagnostic confidence in reviewing WSI. The display system includes Barco's I-Guard front sensor, MediCal QAWeb quality assurance service, Barco's Uniform Luminance Technology to reduce non-uniformities in luminance and color, and built-in stabilization technology.
Although primary diagnosis in digital pathology is not currently approved by the FDA, recent scientific studies and anecdotal evidence indicates growing promise and interest in the technology, according to Duluth, Ga.-based Barco.
At UPMC, researchers conducted a study in which 60 WSI cases were viewed over a three-month period using five different systems: a standard 14-inch laptop computer display, a standard 24-inch desktop display, an optical microscope and two different medical grade displays, one of which was a Barco Coronis Fusion 6MP DL system. The purpose of the study was to compare the user experience among different display options.
The Coronis Fusion 6MP DL medical display ranked comparably to the optical microscope for image quality and diagnostic confidence in reviewing WSI. The display system includes Barco's I-Guard front sensor, MediCal QAWeb quality assurance service, Barco's Uniform Luminance Technology to reduce non-uniformities in luminance and color, and built-in stabilization technology.
Although primary diagnosis in digital pathology is not currently approved by the FDA, recent scientific studies and anecdotal evidence indicates growing promise and interest in the technology, according to Duluth, Ga.-based Barco.